it's all in swedish tho ...
Follicum
Collapse
X
-
-
BUMP.
I think that they have had a couple of "good" news lately and haven't seen any posts about this.
They were noted in the stock market this november and have had a few pretty good news since that.(toxic studies went well,
They have done some studies that finnished and they are aiming to do the human trials this year. In a couple of days they are going to have a meeting with some kind of european medecin agency.
They are also trying to get partners(licensing) to make this happen asap.
I think that the website is better updated atm but i'm not sure.
We have developed a derma cosmetic product, FOL005, for boosting hair and supporting healthy hair growth. Our objective is to launch it in the US, as the
also here is one of their presentation, in swedish.
https://www.youtube.com/watch?v=-QIOfFx6DVo preclinical results: 12.44 - I'm not the right person to translate/summarize it though.
atm it seems that they are able to block the hairgrowth on human, but in mice it's the other way around(If i'm not wrong,they did regrow a whole back of a mouse with just a couple of injections/week) and they think that it's possible to make that on humans aswell.Comment
-
Looking at the "History" section of the Follicum website http://www.follicum.se/?page_id=21, this is another collaboration project with Prof. Ralf Paus. So it has some credibility.Comment
-
News
Some very interesting updates!
Follicum will participate in the Life Science Day 2015 in Paris on 20 October where it will present its preclinical results for investors.
Check this out:
"Follicum develops pharmaceuticals from manipulated endogenous peptides that directly affect the way hair follicles work. Preclinical efficacy studies show:
- Effective inhibition of hair growth on living human skin tissue
- The drug candidate stimulated hair growth much faster and produced hair growth over a much larger area than minoxidil (the active ingredient in Rogaine® (in-vivo)
- No negative toxicological effects have been shown
As these peptides are found in the human body we believe they will result in safe, efficacious treatments
Potential to be first-in-class and first-in-category pharmaceuticals"
Host in-person, virtual, and hybrid networking events and communities with ease. Let your participants connect with the help of an AI recommender.
According to their website, they will also participate at the World Congress For Hair Research in Miami later this year.
Comment
-
Thanks Lionsmane for this info. I saw also, that during the congress they will be presenting results of their trial:
The German research group which has generated important parts of Follicum’s research data on human skin will present their results both as a poster and in an oral presentation at the World Congress for Hair Research. The congress takes place in Miami in Florida, USA, on 18-21 November 2015.Comment
-
There are no pictures available of the initial results vs. minox. That research was done at a 3rd party research lab in India. Also, those results were from mice.
I don't see any need for Follicum to build hype. They're going the pharmaceutical drug route which involves clinical trials and takes a few years. The results will speak for themselves. I've taken a close look at what they're up to, to me they're the real deal.Comment
-
More planned trials are always good news but... results on mice are worthless, no reason for optimism.Comment
-
-
follicum translation
FOLLICUM: https://www.youtube.com/watch?v=-QIOfFx6DVo
Can someone translate this?Comment
-
Last edited by Winston; 01-19-2016, 04:10 PM.Comment
-
I think studies on mice are quite useful. Actually, the top scientists around the world decidedly choose mice as their best known model for doing hair growth research. These are people who are sometimes involved in 10+ years of clinical research.Comment
-
It's a shit model for AGA actually. But hey what other model can they choose from? Jup, none. So they need to go with mice because they have no other choice.Last edited by Winston; 01-19-2016, 04:10 PM.Comment
Comment